DexCom (DXCM) just received FDA clearance for Smart Basal, a new device designed to help adults with Type 2 diabetes optimize their insulin dosing using personalized, real-time sensor data. This ...
DexCom's stock narrative has shifted as analysts lower their fair value estimate from $98.40 to $84.96, marking a significant downward revision in the price target. This adjustment is primarily driven ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Abstract: This paper proposes a deep learning (DL) framework that leverages customer multidimensional click sequence data on e-commerce platforms to predict purchase probabilities and optimize ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. I must take exception to Rob Neal’s Nov. 3 op-ed titled “Maine’s elder ...
LOS ANGELES, Nov. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company ...
Fintel reports that on October 31, 2025, Canaccord Genuity maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation. Analyst Price Forecast Suggests 75.44% Upside As of October 30, 2025 ...
(AP) - Instacart said Friday it will offer customers who receive SNAP benefits 50% on their next grocery order to ease strain as the government prepares to cut off food aid payments. Instacart said ...
Dexcom Inc. executives may have thought a $30 million beat of the consensus estimates for third quarter revenue and 20% growth year-over-year provided a treat to shareholders, but investors seemed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback